John M Carr

US Patent:

6508808, Jan 21, 2003

Filed:

Dec 21, 2000

Appl. No.:

09/748099

Inventors:

John P. Carr - Sunnyvale CA
James B. Eckenhoff - late of Los Altos CA

Assignee:

Alza Corporation - Mountain View CA

International Classification:

A61K 948

US Classification:

6048921, 6048901, 424422, 424457

Abstract:

An osmotic delivery system for controlled delivery of a beneficial agent includes an implant capsule having a beneficial agent reservoir, an osmotic agent which expands on contact with fluid imbibed through a permeable membrane retained by the implant capsule, a delivery port, and a valve for opening and closing the delivery port. When the osmotic agent expands, a pressure is exerted against a separating member positioned between the beneficial agent reservoir and the osmotic agent. The separating member moves within the capsule, thereby forcing the valve to move a distance such that the beneficial agent can exit the reservoir through the delivery port.

US Patent:

6682522, Jan 27, 2004

Filed:

Dec 4, 2002

Appl. No.:

10/310742

Inventors:

John P. Carr - Sunnyvale CA
James B. Eckenhoff - late of Los Altos CA

Assignee:

Alza Corporation - Mountain View CA

International Classification:

A61K 948

US Classification:

6048921, 6048901, 424422, 424457

Abstract:

An osmotic delivery system for controlled delivery of a beneficial agent includes an implant capsule having a beneficial agent reservoir, an osmotic agent which expands on contact with fluid imbibed through a permeable membrane retained by the implant capsule, a delivery port, and a valve for opening and closing the delivery port. When the osmotic agent expands, a pressure is exerted against a separating member positioned between the beneficial agent reservoir and the osmotic agent. The separating member moves within the capsule, thereby forcing the valve to move a distance such that the beneficial agent can exit the reservoir through the delivery port.

US Patent:

8266031, Sep 11, 2012

Filed:

Jul 28, 2010

Appl. No.:

12/845591

Inventors:

Mark Norris - San Francisco CA, US
Shaun Bodington - Montara CA, US
Nicola Stiff - Mill Valley CA, US
Raymond Olson - Half Moon Bay CA, US
Janet Martin - Long Grove IL, US
Rosann Woods - Mill Valley CA, US
John Carr - San Francisco CA, US

Assignee:

Visa U.S.A. - San Francisco CA

International Classification:

G06Q 40/00

US Classification:

705 35, 705 39

Abstract:

Systems and methods are provided to facilitate the sharing of account features. In one aspect, a system includes a transaction handler to process transactions and a data warehouse to record the transactions and store account data identifying account features of separate accounts, such as a second account having a feature and a first account without this feature. Account holders of the first and second accounts are in a same household and thus, in accordance with a set of rules, eligible to share the account features. A portal is configured to receive a request identifying the first account and to determine whether a transaction initiated in the first account and qualified for a benefit of the account feature is entitled to the benefit; and if so, a notification engine is to transmit a notification message to an account holder of the first account.

US Patent:

20070027105, Feb 1, 2007

Filed:

Jul 24, 2006

Appl. No.:

11/492153

Inventors:

Gunjan Junnarkar - Palo Alto CA, US
Michael DesJardin - Sunnyvale CA, US
John Carr - Sunnyvale CA, US

Assignee:

ALZA CORPORATION - MOUNTAIN VIEW CA

International Classification:

A61K 31/7024
C07H 13/02
A61K 47/00

US Classification:

514053000, 536119000, 514777000

Abstract:

The present invention is related to methods for lowering peroxide levels in sucrose acetate isobutyrate formulations and to composition used in and formed by such methods.

US Patent:

20110022414, Jan 27, 2011

Filed:

Jun 30, 2010

Appl. No.:

12/827717

Inventors:

Yaorong Ge - Winston-Salem NC, US
John Jeffrey Carr - Winston-Salem NC, US

International Classification:

G06Q 50/00
G06Q 10/00
H04L 9/32
G06F 21/00
G06F 15/16

US Classification:

705 3, 726 7, 235380

Abstract:

A method and apparatus for personally controlled sharing of medical image and other health data are disclosed. According to one aspect, the subject matter described herein includes a method for patient mediated access to patient health information maintained by different healthcare facilities and other health record repositories. The methods includes, using a central key server and a plurality of data servers local to healthcare facilities and other health record repositories. At the central key server, a patient controlled registry of access keys that control access to patient health information maintained by different healthcare facilities is provided. The central key server receives, from a data server of a first healthcare facility, a request for an access key that controls access to health information for a patient maintained by a second healthcare facility. In response to the request, the central key server authenticates credentials of the patient and the first healthcare facility, verifies permission from the patient to release the access key to the first healthcare facility, locates the access key for the health information for the patient at the second healthcare facility, and provides the access key to the first healthcare facility. The access key is used by the data server of the first healthcare facility to obtain health information for the patient directly from the data server of the second healthcare facility after successful authentication and verification by the second healthcare facility.

US Patent:

20110029367, Feb 3, 2011

Filed:

Jul 28, 2010

Appl. No.:

12/845645

Inventors:

Ray Olson - Half Moon Bay CA, US
Janet Martin - Long Grove IL, US
Shaun Bodington - Montara CA, US
Nicola Stiff - Mill Valley CA, US
Mark Norris - San Francisco CA, US
Rosann Woods - Mill Valley CA, US
John Carr - San Francisco CA, US

Assignee:

VISA U.S.A. INC. - San Francisco CA

International Classification:

G06Q 30/00
G06Q 40/00

US Classification:

705 1425, 705 39, 705 35

Abstract:

Systems and methods are provided to facilitate the generation and notification of transactions associated with account features. In one aspect, a system includes a transaction handler to process transactions and a data warehouse to store transaction data recording the transactions, account data identifying at least one account feature of an account, and rules data identifying at least one qualification requirement. The system further includes a feature offer engine to use the rules data to monitor the transactions in the account to identify a first transaction, a notification engine to provide the account holder with an offer associated with a first account feature in real time with processing of the first transaction, and a portal to receive an approval of a second transaction in accordance with the offer.

US Patent:

20120330005, Dec 27, 2012

Filed:

Nov 21, 2011

Appl. No.:

13/301727

Inventors:

Gunjan Junnarkar - Palo Alto CA, US
Michael A. DesJardin - Sunnyvale CA, US
John Patrick Carr - Sunnyvale CA, US

International Classification:

C07H 1/06
C07H 13/04

US Classification:

536119

Abstract:

The present invention is related to methods for lowering peroxide levels in sucrose acetate isobutyrate formulations and to composition used in and formed by such methods.

US Patent:

59723700, Oct 26, 1999

Filed:

Jan 28, 1999

Appl. No.:

9/238159

Inventors:

James B. Eckenhoff - late of Los Altos CA
Leslie A. Holladay - Mountain View CA
John Joseph Leonard - Cupertino CA
Iris K. M. Leung - San Jose CA
Sally A. Tao - San Jose CA
Judy A. Magruder - Mountain View CA
John P. Carr - Sunnyvale CA
Jeremy C. Wright - Los Altos CA

Assignee:

Alza Corporation - Palo Alto CA

International Classification:

A61F 200
A61K 914
A61K 3800
C07K 1702

US Classification:

424424

Abstract:

The present invention provides improved compositions for improving the chemical and physical stability of peptides and proteins. The invention provides a liquid beneficial agent formulation containing a liquid suspension comprising at least 5% by weight beneficial agent and having a viscosity and beneficial agent size which minimizes settling of the agent in suspension over the extended delivery period.